US Patent 11129903 Multispecific antigen-binding molecules and uses thereof
Patent 11129903 was granted and assigned to Regeneron Pharmaceuticals, Inc. on September, 2021 by the United States Patent and Trademark Office.
Is a
Date Filed
July 6, 2016
Date of Patent
September 28, 2021
Patent Application Number
20160706
Patent Jurisdiction
Patent Number
Find more entities like US Patent 11129903 Multispecific antigen-binding molecules and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
